Intervention studies on cancer

European Journal of Cancer Prevention

Volumn 8, Issue 2, 1999, Pages 91-103

  Young, K J ^a   Lee N, P ^a  

^a PN Lee Statistics and Computing Ltd   (United Kingdom)

Author keywords

Cancer; Intervention trials; Validating epidemiology

Indexed keywords

BIOLOGICAL MARKER; PYRIDOXINE; RIBOFLAVIN; VITAMIN D; ZINC;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; DIETARY FIBER; DIETARY INTAKE; HUMAN; LIFESTYLE; LOW FAT DIET; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0032922351     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199904000-00003     Document Type: Review

References (54)

1. Alfthan O, Tarkkanen J, Gröhn P et al. (1983). Tigason© (etretinate) in prevention of recurrence of superficial - bladder tumors. A double-blind clinical trial. Eur Urol 9: 6-9.
2. AIpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-35.
3. Arnold AM, Browman GP, Levine MN et al. (1992). The effect of synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 65: 737-43.
4. Black HS, Herd JA, Goldberg LH et al. (1994). Effect of a lowfat diet on the incidence of actinic keratosis. N Engl J Med 330: 1272-5.
5. Blot WJ, Li JY, Taylor PR et al. (1993). Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85: 1483-92.
6. Bolla M, Lefur R, Ton Van J et al. (1994). Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. Eur J Cancer 30A: 767-72.
7. Boyd NF, Cousins M, Beaten M et al. (1988). Clinical trial of low-fat, high-carbohydrate diet in subjects with mammographie dysplasia: report of early outcomes. J Natl Cancer Inst 80: 1244-8.
8. Buiatti E (1994). Intervention trials of cancer prevention: results and new research programmes. In IARC Technical Report No. 18. IARC, Lyon, pp. 52.
9. Bussey HJR, DeCosse JJ, Deschner EE et al. (1982). A randomized trial of ascorbic acid in polyposis coli. Cancer 50: 1434-9.
10. Butterworth CE Jr, Hatch KD, Gore H et al. (1982). Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Niitr 35: 73-82.
11. Butterworth CE Jr, Hatch KD, Soong S-J et al. (1992). Oral folic acid supplementation fcr cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 166: 803-9.
12. Childers JM, Chu J, Voigt LF et al. (1995). Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group intergroup study. Cancer Epidemiol Biomarkers Prev 4: 155-9.
13. Clark L, Turnbull B, Combs G (1996). The nutritional prevention of cancer with selenium: a randomized trial [Abstract]. Am J Epidemiol 143: 59.
14. DeCosse JJ, Miller HH, Lesser ML (1989). Effect of wheat fibre and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 81:1290-7.
15. De Vet HCW, Knipschild PG, Willebrand D et al. (1991). The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 44: 273-83.
16. Ederer F, Leren P, Turpeinen O et al. (1971). Cancer among men on cholesterol-lowering diets: experience from five clinical trials. Lancet ii: 203-6.
17. Fryer JH (1961). The role of nutrition in oral leukoplakia including a therapeutic trial of topical vitamin A. Ann Otol Rliinol Laiyngo 170: 102-17.
18. Gann PH, Manson JE, Glynn RJ et al. (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. / Natl Cancer Inst 85: 1220-4 .
19. Giardiello FM, Hamilton SR, Krush AJ et al. (1993). Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. NEnglJMed 328:1313-16.
20. Greenberg ER, Baron JA, Stukel TA et al. (1990). A clinical trial of beta-carotene to prevent basal-cell and squamouscell cancers of the skin. N Engl J Med 323: 789-95.
21. Greenberg ER, Baron JA, Tosteson TD et al. (1994). A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N EnglJMed 331: 141-7.
22. Hakama M, Beral V, Cullen JW et al. (1990). Evaluating Effectiveness of Primary Prevention of Cancer. IARC, Lyon.
23. Han J, Jiao L, Lu Y et al. (1990). Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prévention agent and as a cancer chemotherapeutic agent. In Vivo 4: 153-60.
24. Heimburger DC, Alexander CB, Birch R et al. (1988). Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. JAMA 259: 1525-30.
25. Hennekens CH, Buring JE, Manson JE et al. (1996). Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145-9.
26. Hong WK, Doos WG (1985). Chemoprevention of head and neck cancer. Potential use of retinoids. Otolaryngol Clin North Am 18: 543-9.
27. Hong WK, Endicott J, Itri LM et al. (1986). 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-5.
28. Hong WK, Lippman SM, Itri LM et al. (1990). Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795-801.
29. Johnson JE, Ringsdorf WM Jr, Cheraskin E (1963). Relationship of vitamin A and oral leukoplakia. Arch Dermalol 88: 607-12.
30. Krishnaswamy K, Prasad MPR, Krishna TP et al. (1995). A case study of nutrient intervention of oral pre-cancerous lesions in India. EurJ Cancer B Oral Oncol 31B: 41-8.
31. Labayle D, Fischer D, Vielh P et al. (1991). Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635-9.
32. Lee JS, Lippman SM, Benner SE et al. (1994). Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 12: 937-45.
33. Leren P (1970). The Oslo Diet-Heart study: eleven-year report. Circulation 42: 935-42.
34. Li JY, Blot WJ, Taylor PR (1993). Preliminary report on the results of nutrition prevention trials of cancer and other common diseases among residents in Linxian (China). Cluing Hua Cluing Liu Tsa Chill 15: 165-81 (in Chinese).
35. London RS, Sundaram GS, Murphy L et al. (1985). The effect of vitamin E on mammary dysplasia: a double-blind study. Obstet Gynecol 65: 104-6.
36. MacLennan R, Bain C, Macrae F et al. (1991). Design and implementation of the Australian polyp prevention project. In Large bowel cancer: policy, prevention, research and treatment (eds Rozen P, Reich CB, Winawer SJ, Front). Castrointest Res 18: 60-73.
37. McKeown-Eyssen G, Holloway C, Jazmaji V et al. (1988). A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 48: 4701-5.
38. McKeown-Eyssen GE, Nright-See E, Bruce WR et al. (1994). A randomized trial of a low-fat high-fibre diet in the recurrence of colorectal polyps. J Clin Epidemiol 47: 525-36.
39. Meyskens FL Jr, Emerson SS, Pelot D et al. (1994). Dose deescalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 86: 1122-30.
40. Munoz N, Wahrendorf J, Jian Bang Letal. (1985). No effect of riboflavin, retinol, and zinc on prevalence of pre-cancerous lesions of the oesophagus. A randomized double-blind intervention study in a high-risk population in China. Lancet ii: 111-14.
41. Omenn GS, Goodman GE, Thornquist MD et al. (1996). Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engt J Med 334: 1150-5.
42. Pastorino U, Infante M, Maioli M et al. (1993). Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-22.
43. Pearce ML, Dayton S (1971). Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet i: 464-7.
44. Pedersen H, Wolf H, Jensen SK et al. (1984). Administration of a retinoid as prophylaxis of recurrent non-invasive bladder tumors. Scand J Urol Nephrol 18: 121-3.
45. Ponz de Leon M, Roncucci L, Di Donato P et al. (1989). Vitamins A, C and E and lactulose in the prevention of recurrence of adenomatous polyps: preliminary results of a controlled study. Gut 30: A1511-2.
46. Roncucci L, Di Donato P, Carati L et al. (1993). Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 36: 227-34.
47. Stam J, Strankinga WFM, Fikkert JJ et al. (1990). Vitamins and lung cancer. Lung Suppl: 1075-81.
48. Stich HF, Rosin MP, Hornby AP et al. (1988). Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42: 195-9.
49. Studer UE, Biedermann C, Chollet D et al. (1984). Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicentre trial in Switzerland. J Urol 131: 47-9.
50. Tangrea JA, Edwards BK, Taylor PR et al. (1992). Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial./Natl CancerInst 84: 328-32.
51. Thompson SC, Jolley D, Marks R (1993). Reduction of solar kératoses by regular sunscreen use.NEnglJMed 329:114751.
52. Young KJ, Lee PN (1997). Intervention Studies on Cancer. Available from PN Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, UK or on the Internet at http://www.pnlee.demon.co.uk.
53. Yu M-W, You S-L, Chang A-S et al. (1991). Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 51: 5621-5.
54. Zaridze D, Evstifeeva T, Boyle P (1993). Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol 3: 225-34.